John Kennedy, MD, MSc
Pulmonologist, Division of Pulmonary Medicine
Instructor of Medicine, Harvard Medical School
Image
John Kennedy, MD, MSc
Pulmonologist, Division of Pulmonary Medicine
Instructor of Medicine, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Salisbury University
1999
Salisbury
MD
Graduate School
Trinity College Dublin
2003
Dublin
Ireland
Medical School
University of New Mexico
2010
Albuquerque
NM
Residency
Internal Medicine and Pediatrics
University of Rochester
2014
Rochester
NY
Fellowship
Pulmonary and Critical Care Medicine
Brigham and Women's Hospital
2017
Boston
MA
Certifications
American Board of Internal Medicine (General)
American Board of Internal Medicine (Critical Care Medicine)
American Board of Internal Medicine (Pulmonary Disease)
Publications
Bronchial Stenosis after Lung Transplant: Risks Factors and Clinical Outcomes View Abstract
A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-a biologic therapy. View Abstract
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials. View Abstract
Processes and outcomes from a clinical genetics e-consultation service managed by a primary care physician champion. View Abstract
Limited Effect of Prevention Strategies on Incidence of Clinically Detectable Venous Thromboembolism After Lung Transplantation. View Abstract
An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestations. View Abstract
The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosis. View Abstract
1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver disease. View Abstract
A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings. View Abstract
Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short Telomeres. View Abstract
New Developments in the Pathogenesis of Pulmonary Cysts in Birt-Hogg-Dubé Syndrome. View Abstract
Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndrome. View Abstract
Utility of Comprehensive Assessment for Hepatic Fibrosis in Lung Transplant Candidates. View Abstract
Loss of FLCN inhibits canonical WNT signaling via TFE3. View Abstract
Mechanisms of pulmonary cyst pathogenesis in Birt-Hogg-Dube syndrome: The stretch hypothesis. View Abstract
A 14-Year-Old Boy With Mycoplasma pneumoniae-Associated Mucositis and Intracranial Hypertension. View Abstract
Improved quantitative analysis of primary bone marrow megakaryocytes utilizing imaging flow cytometry. View Abstract
Chaperone-mediated autophagy is defective in mucolipidosis type IV. View Abstract
Mechanism of interferon-gamma-induced increase in T84 intestinal epithelial tight junction. View Abstract
Cellular and molecular mechanisms of heat stress-induced up-regulation of occludin protein expression: regulatory role of heat shock factor-1. View Abstract
Etiology of decreased gastric nitric oxide in the critically ill. View Abstract
Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. View Abstract
Association of a genetic marker at the corticotropin-releasing hormone locus with behavioral inhibition. View Abstract
Cloning and characterization of the mouse Mcoln1 gene reveals an alternatively spliced transcript not seen in humans. View Abstract
A physical and transcript map of the MCOLN1 gene region on human chromosome 19p13.3-p13.2. View Abstract
Genetic association analysis of behavioral inhibition using candidate loci from mouse models. View Abstract
Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. View Abstract